LMHEMDNV2024-03 | Self Study Module: "Updates in Asthma Care: What's New in 2024"

Carleen Spitzer, M.D.

2/19/2024 - 2/19/2026

Question Title

* 1. Learner Information
By signing this form, I attest that I have completed the participant requirements for this CME activity. Any patient/case information will be kept confidential.

First and Last Name and Credentials (i.e. Jane Doe, M.D.)

Date:

Number of AMA PRA Category 1 Credits™ Claiming (i.e., .50 or 1)

Question Title

* 2. Objectives were met for this activity, and this activity has enhanced my overall knowledge or abilities.

Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

Question Title

* 3. Please rate this conference

Excellent - The speaker, topic and presentation were superior. The presenter demonstrated substantive knowledge of the topic

Good - Speaker was knowledgeable, presentation was satisfactory.

Fair – Speaker and presentation were average.

Poor – Speaker and presentation were unsatisfactory.

Question Title

* 4. Was this activity engaging and/or interactive

Yes

Question Title

* 5. Are the written materials helpful, and will they be useful references in the future?

Yes

Question Title

* 6. This CE Activity….

	Met my learning needs	Was relevant to my current scope of practice	Contributed to my professional growth.	Helped me learn skills and concepts that will allow me to be effective and strategic in my practice	Allowed me to increase my connections with peers.	Provided me with new ideas and resources.
Select all that apply	Select all that apply Met my learning needs	Select all that apply Was relevant to my current scope of practice	Select all that apply Contributed to my professional growth.	Select all that apply Helped me learn skills and concepts that will allow me to be effective and strategic in my practice	Select all that apply Allowed me to increase my connections with peers.	Select all that apply Provided me with new ideas and resources.

Other (please specify)

Question Title

* 7. Identify any specific changes that you plan to implement in your professional practice as a result of information you obtained as an attendee of this CME activity:

	None - Retired from Practice	Patient Work-up	Treatment Plans	Patient Education
Select all that apply.	Select all that apply. None - Retired from Practice	Select all that apply. Patient Work-up	Select all that apply. Treatment Plans	Select all that apply. Patient Education

Other (please specify)

Question Title

* 8. This activity changed, enhanced, or improved my:

	Knowledge	Competency	Performance	Patient Outcomes	Communication skills	Practice-based systems	System-based practices
Select all that apply	Select all that apply Knowledge	Select all that apply Competency	Select all that apply Performance	Select all that apply Patient Outcomes	Select all that apply Communication skills	Select all that apply Practice-based systems	Select all that apply System-based practices

Question Title

* 9. Activity was free of commercial bias

Yes

Question Title

* 10. Activity was evidence-based

Yes

Question Title

* 11. What are the impediments to change?

	Cost	Insurance/reimbursement issues	Lack time to assess/counsel patients	Patient compliance issues	Lack of administrative support/resources	Lack of consensus of professional guidelines
Select all that apply.	Select all that apply. Cost	Select all that apply. Insurance/reimbursement issues	Select all that apply. Lack time to assess/counsel patients	Select all that apply. Patient compliance issues	Select all that apply. Lack of administrative support/resources	Select all that apply. Lack of consensus of professional guidelines

Other (please specify)

Question Title

* 12. Select the correct answer.

	True	False
As needed ICS LABA is now the preferred, first-line therapy for someone with mild asthma.	As needed ICS LABA is now the preferred, first-line therapy for someone with mild asthma. True	As needed ICS LABA is now the preferred, first-line therapy for someone with mild asthma. False
LAMA therapy is an appropriate addition to a patient's therapy who remains poorly controlled on a medium-dose ICS/LABA	LAMA therapy is an appropriate addition to a patient's therapy who remains poorly controlled on a medium-dose ICS/LABA True	LAMA therapy is an appropriate addition to a patient's therapy who remains poorly controlled on a medium-dose ICS/LABA False
Mepolizumab is approved for patients with asthma who have elevated IGE.	Mepolizumab is approved for patients with asthma who have elevated IGE. True	Mepolizumab is approved for patients with asthma who have elevated IGE. False

Question Title

* 13. COMMITMENT TO CHANGE: Please identify one or two specific measurable changes you wish to implement in your practice as a result of this education.

LMHEMDNV2024-03 | Self Study Module: "Updates in Asthma Care: What's New in 2024"

Carleen Spitzer, M.D.

Question Title

* 1. Learner InformationBy signing this form, I attest that I have completed the participant requirements for this CME activity. Any patient/case information will be kept confidential.

Question Title

* 2. Objectives were met for this activity, and this activity has enhanced my overall knowledge or abilities.

Question Title

* 3. Please rate this conference

Question Title

* 4. Was this activity engaging and/or interactive

Question Title

* 5. Are the written materials helpful, and will they be useful references in the future?

Question Title

* 6. This CE Activity….

Question Title

* 7. Identify any specific changes that you plan to implement in your professional practice as a result of information you obtained as an attendee of this CME activity:

Question Title

* 8. This activity changed, enhanced, or improved my:

Question Title

* 9. Activity was free of commercial bias

Question Title

* 10. Activity was evidence-based

Question Title

* 11. What are the impediments to change?

Question Title

* 12. Select the correct answer.

Question Title

* 13. COMMITMENT TO CHANGE: Please identify one or two specific measurable changes you wish to implement in your practice as a result of this education.

Question Title

* 14. Comments on this activity, or suggestions for CME topics.

* 1. Learner Information
By signing this form, I attest that I have completed the participant requirements for this CME activity. Any patient/case information will be kept confidential.